Screening for hepatitis B may be cost-effective for more of the population, analysis shows
Tuesday, May 3, 2011 - 18:30
in Health & Medicine
New research provides evidence that current prevention and screening standards for hepatitis B are worth the cost and may even need expansion to include more of the population, further helping prevent the spread of this life-threatening disease.